Oral immunotherapy for cow’s milk allergy in children: a systematic review and meta-analysis

Yan Wang, Shunli Liu, Meizhu Lu, Jingyu Guo, Chen Lv, Lan HuangFrontiers in Immunology 2025 · DOI

Abstract: Cow’s milk allergy (CMA) is a prevalent pediatric condition traditionally managed through strict dietary avoidance. This systematic review and meta-analysis of 19 randomized controlled trials (RCTs) evaluates the efficacy and safety of oral immunotherapy (OIT) as an active intervention. The study confirms that OIT significantly improves desensitization, particularly in children over age four, and induces measurable immunological shifts. However, the risk of late-stage complications such as eosinophilic esophagitis (EoE) necessitates long-term clinical monitoring.

Introduction

Cow’s milk allergy (CMA) is one of the most prevalent food allergies in children, often leading to strict dietary avoidance. This "avoidance-only" strategy is fraught with challenges: it increases the risk of accidental exposure, imposes a significant financial burden on families, and can lead to nutritional deficiencies and stunted growth.

While oral immunotherapy (OIT)—the practice of gradually increasing allergen intake to induce tolerance—has emerged as a promising alternative, clinical results have historically been inconsistent. This paper seeks to resolve these discrepancies by performing a rigorous meta-analysis of existing RCTs to quantify the efficacy and safety of OIT for pediatric CMA.

Methods

The researchers conducted a systematic review following PRISMA guidelines, searching major databases (PubMed, EMBASE, Cochrane Library, and Scopus) for RCTs published through August 2024. The study employed a random-effects model to account for expected heterogeneity across different clinical settings. Key metrics included Relative Risk (RR) for dichotomous outcomes like successful desensitization and Standardized Mean Difference (SMD) for continuous outcomes such as changes in antibody titers.

Figure 1: PRISMA flow diagram of the study selection process.

Study Selection and Datasets

As illustrated in the flow diagram above, the meta-analysis synthesized data from 19 RCT articles involving a total of 815 participants. The studies spanned North America, Europe, and Asia, providing a broad geographic perspective. Control groups typically involved either strict avoidance, placebo, or the use of soy-based/extensively hydrolyzed formulas.

Key Insights and Results

The Age Threshold

OIT was significantly more effective in children aged 4 and older (RR 4.43) compared to those under 4 (RR 2.34). The authors suggest this is because younger children have a higher rate of spontaneous resolution, which can mask the specific therapeutic effect of OIT in clinical trials.

Immunological Rebalancing

The study provides quantitative evidence that OIT induces a measurable shift in the immune system. It showed a significant decrease in milk-specific IgE (the antibody responsible for immediate reactions) and an increase in IgG4, which is associated with immune tolerance. Specifically, OIT led to a decrease in serum cow milk protein-specific IgE (SMD -0.42) and casein-specific IgE (SMD -0.54).

Desensitization and Tolerance

OIT significantly facilitated desensitization with a pooled RR of 2.51 (95% CI: 1.54–4.09). Furthermore, the amount of milk protein a child could tolerate before reacting (the tolerance threshold) increased significantly, with an SMD of 3.58.

Raw vs. Baked Milk

Interestingly, the meta-analysis found that OIT using raw milk showed a statistically significant advantage in desensitization compared to controls, whereas baked or heated milk interventions did not show a statistically significant advantage in this specific pooled dataset.

Safety Profile and Eosinophilic Esophagitis (EoE)

The risk of adverse reactions was higher in the OIT group but not statistically significant compared to the control group (RR 2.05, 95% CI 0.96–4.37). However, high heterogeneity ($I^2 = 81.5\%$) suggests safety varies wildly based on the specific protocol used.

A critical finding was the risk of Eosinophilic Esophagitis (EoE) as a late-stage complication. By expanding their search to cohort studies, the authors identified a 4.0% incidence rate of biopsy-confirmed EoE in children receiving OIT, highlighting the need for long-term gastrointestinal monitoring.

Conclusion and Future Directions

While OIT is a powerful tool for inducing desensitization in children with CMA, the high heterogeneity among current studies points to a need for standardized protocols. Future research should focus on establishing clear definitions for maintenance doses and conducting long-term studies (beyond two years) to track the persistence of tolerance and the incidence of late-onset complications like EoE.

Summary updated

Abstract

https://www.crd.york.ac.uk/PROSPERO/recorddashboard, identifier CRD42024541769.
BibTeX
@inproceedings{wang2025oral,
  author = {Yan Wang and Shunli Liu and Meizhu Lu and Jingyu Guo and Chen Lv and Lan Huang},
  title = {{Oral immunotherapy for cow’s milk allergy in children: a systematic review and meta-analysis}},
  booktitle = {Frontiers in Immunology},
  year = {2025},
  doi = {10.3389/fimmu.2025.1570050},
}
Figure